Free Xbrane Biopharma AB (XBRANE) Technical Analysis Signals

Overal Signal
Neutral
Last Update / Period
11 Jun / Daily
Category/Currency
Stocks/USD
Exchange/Country
XSTO/Sweden

Xbrane Biopharma AB (XBRANE) signal with technical analysis on 11 Jun

On 11 Jun, we conducted a comprehensive technical analysis of Xbrane Biopharma AB (XBRANE), considering 99 signals with intricate details. Here are the key findings: 4 signals suggested buy strategies, while 4 indicated sell strategies. The remaining 91 signals remained neutral without offering a specific direction.

EMA Crossover 1MIDPOINT Slope 3SAR CrossoverPLUS_DI Threshold 2ROCR Threshold 1BOP Smoothed ThresholdStochastic RSI Signal



Overall Strategy:
Buy Signals: 4
Sell Signals: 4
Neutral Signals: 91
Result: This strategy leads to a Neutral position.

Disclaimer! Please exercise caution and thorough consideration before making any financial decisions. It's important to note that our signals are based solely on daily price changes and do not take into account external factors such as news, market sentiment, or company developments. We strongly recommend considering all relevant factors and conducting your own research.

Useful Tips: To make the most informed decisions about your Xbrane Biopharma AB (XBRANE) investments, we highly recommend visiting the "Magic Prediction" AI models signals website. They provide free signals, and if one aligns with ours, it is likely to be a reliable indicator, as we have observed over time.


These support levels should be considered carefully in the context of broader market trends and indicators. Staying alert and consistently analyzing the market will allow you to make informed decisions while trading Xbrane Biopharma AB (XBRANE). Paying attention to these support levels will help you adapt to the dynamic nature of the market and make smarter trading choices. Second Resistance Level: 12.3
If the upward trend continues with significant strength, we may see Xbrane Biopharma AB (XBRANE) cross the second resistance level at 12.3. This would indicate a major upside move and a promising direction for our position.

Third Resistance Level: 13.8
For a more comprehensive analysis, consider the possibility of Xbrane Biopharma AB (XBRANE) not only breaking the second resistance level but also holding its price above this mark. If this trend continues in the coming days, Xbrane Biopharma AB (XBRANE) could potentially reach the third resistance level at 13.8.
It's crucial to closely monitor these resistance levels and consider them in the context of broader market trends and indicators. To make informed decisions when trading Xbrane Biopharma AB (XBRANE), stay vigilant and continuously analyze the market. Focusing on these resistance levels, along with broader market dynamics, will help you make smarter trading decisions and adapt to the changing market conditions.

Xbrane Biopharma AB (XBRANE) technical analysis chart

Xbrane Biopharma AB (XBRANE) support and resistance levels

Name Level1 Level2 Level3 Level4 Level5
Resistance 11.8 12.3 13.8 -- --
Support 8.94 -- -- -- --
 Xbrane Biopharma AB (XBRANE) Support and Resistance area (11 Jun)  Xbrane Biopharma AB (XBRANE) Support and Resistance area (11 Jun)

Xbrane Biopharma AB (XBRANE) signals list for 11 Jun

Overall Signals

Xbrane Biopharma AB (XBRANE) candlestick patterns on 11 Jun

Today's Xbrane Biopharma AB (XBRANE) Candle Patterns List:

Xbrane Biopharma AB (XBRANE) technical analysis over the past days

# Date Overal Signals ALL Signals
1 11 Jun N EMA Price Cross 1EMA Price Cross 2EMA Price Cross 3EMA Price Cross 4WMA Crossover 1MIDPOINT Slope 2MIDPOINT Slope 4TEMA Price 1TRIMA Slope 3PLUS_DI Threshold 1PLUS_DI Threshold 2BOP Smoothed ThresholdSTOCH Normal Zone CrossBBANDS Breakout 1Stochastic RSI Signal
2 10 Jun S EMA Price Cross 1EMA Price Cross 2EMA Price Cross 3EMA Price Cross 4KAMA 3EMA Crossover 1WMA Crossover 2TEMA Price 2TEMA Price 3TRIMA Slope 1TRIMA Slope 3PLUS_DI Threshold 1PLUS_DI Threshold 2BOP Smoothed ThresholdMACD Crossover 1BBANDS Breakout 1Volume SpikeADXR with DI+/DI-Ichimoku 1Ichimoku 2Ichimoku 3Daily Pivot Point 1CMO Divergence 1
3 09 Jun B DEMA 3EMA Price Cross 1EMA Price Cross 2EMA Price Cross 3EMA Price Cross 4EMA Crossover 1MIDPOINT Slope 3MIDPOINT Slope 4T3 Slope 2TEMA Price 3TRIMA Slope 1TRIMA Slope 2TRIMA Slope 3PLUS_DI Threshold 1PLUS_DI Threshold 2ROC Threshold 1ROCR Threshold 2BOP Smoothed ThresholdBBANDS Breakout 1Stochastic RSI SignalIchimoku 2Daily Pivot Point 1Rolling VWAP
4 08 Jun S DEMA 1EMA Crossover 1T3 Slope 2TEMA Price 2TRIMA Slope 2PLUS_DI Threshold 1PLUS_DI Threshold 2ROCR Threshold 1BOP Smoothed ThresholdBBANDS Breakout 1OBV CrossoverVolume SpikeIchimoku 2Rolling VWAPCMO Divergence 1Coppock Curve
5 05 Jun B DEMA 1EMA Price Cross 1EMA Price Cross 2EMA Price Cross 3EMA Price Cross 4WMA Crossover 1MIDPOINT Slope 1MIDPOINT Slope 2MIDPOINT Slope 4T3 Slope 2TEMA Price 1TEMA Price 2TRIMA Slope 1TRIMA Slope 2AROONOSC 1CCI Crossover 1CCI Crossover 3PLUS_DI Threshold 1PLUS_DI Threshold 2Stochastic RSI SignalVolume SpikeElder's Force IndexCMO Divergence 1CMO Divergence 2
6 04 Jun B DEMA 2DEMA 3KAMA 2MIDPOINT Slope 1T3 Slope 1TEMA Price 3TRIMA Slope 1TRIMA Slope 2MOM Crossover 2ROC Threshold 2ROCR Threshold 3BOP Smoothed ThresholdIchimoku 1CMO Divergence 1
7 03 Jun S DEMA 2DEMA 3KAMA 2WMA Crossover 3MIDPOINT Slope 1T3 Slope 1TEMA Price 2TEMA Price 3TRIMA Slope 1TRIMA Slope 2AROONOSC 2PLUS_DI Threshold 2ROC Threshold 2ROCR Threshold 4BOP Smoothed ThresholdPercentage Price OscillatorCMO Divergence 1
8 02 Jun S DEMA 1DEMA 2DEMA 3KAMA 1KAMA 2EMA Crossover 2MIDPOINT Slope 1MIDPOINT Slope 2MIDPOINT Slope 3T3 Slope 1TEMA Price 2TEMA Price 3TRIMA Slope 1ROCR Threshold 4WILLR Exit OverboughtBOP Smoothed ThresholdDaily Pivot Point 1CMO Divergence 1
9 01 Jun S DEMA 1DEMA 2DEMA 3EMA Price Cross 1EMA Price Cross 2EMA Price Cross 3EMA Price Cross 4KAMA 1MIDPOINT Slope 1MIDPOINT Slope 2TEMA Price 1TEMA Price 2TEMA Price 3TRIMA Slope 1TRIMA Slope 3AROONOSC 1AROONOSC 3MOM Crossover 1PLUS_DI Threshold 2ROC Threshold 1ROCR Threshold 2WILLR Exit OversoldBOP Smoothed ThresholdBBANDS Breakout 1Chaikin AD CrossoverChaikin ADOSC Zero CrossEngulfing PatternDEMA with ATR 2DEMA with ATR 3Ichimoku 2Daily Pivot Point 1Rolling VWAPElder's Force IndexCMO Divergence 1
10 29 May S EMA Price Cross 4KAMA 3KAMA 4MIDPOINT Slope 1TEMA Price 2TEMA Price 3TRIMA Slope 1TRIMA Slope 3PLUS_DI Threshold 1PLUS_DI Threshold 2BOP Smoothed ThresholdPercentage Price OscillatorIchimoku 1Ichimoku 2
11 28 May B DEMA 3KAMA 3KAMA 4EMA Crossover 1WMA Crossover 2MIDPOINT Slope 3TEMA Price 2TEMA Price 3TRIMA Slope 2TRIMA Slope 3PLUS_DI Threshold 1PLUS_DI Threshold 2ROCR Threshold 1BOP Smoothed ThresholdMACD Crossover 2Ichimoku 2CMO Divergence 1
12 27 May N EMA Price Cross 4KAMA 3KAMA 4TEMA Price 2TEMA Price 3TRIMA Slope 2TRIMA Slope 3CCI Crossover 2PLUS_DI Threshold 1PLUS_DI Threshold 2TRIX Crossover 1MACD Crossover 1
13 26 May N EMA Price Cross 4KAMA 1KAMA 2KAMA 3KAMA 4T3 Slope 2TRIMA Slope 2TRIMA Slope 3AROONOSC 2MOM Crossover 2PLUS_DI Threshold 1PLUS_DI Threshold 2ROC Threshold 2ROCR Threshold 1ROCR Threshold 3WILLR Exit OversoldWILLR Exit OverboughtBOP Smoothed ThresholdMACD Crossover 1Stochastic RSI SignalIchimoku 2Daily Pivot Point 1CMO Divergence 2
14 25 May B DEMA 1DEMA 2EMA Price Cross 4KAMA 3KAMA 4WMA Crossover 1T3 Slope 2TEMA Price 1TEMA Price 2TEMA Price 3TRIMA Slope 2TRIMA Slope 3CCI Crossover 1CCI Crossover 2MOM Crossover 2PLUS_DI Threshold 1PLUS_DI Threshold 2ROCR Threshold 1ROCR Threshold 3BOP Smoothed ThresholdMACD Crossover 1Daily Pivot Point 1CMO Divergence 1
15 22 May S KAMA 1KAMA 2KAMA 3KAMA 4MIDPOINT Slope 3T3 Slope 1T3 Slope 2TRIMA Slope 1TRIMA Slope 2CCI Crossover 3PLUS_DI Threshold 1PLUS_DI Threshold 2RSI Exit OversoldTRIX Crossover 1BBANDS Breakout 2Stochastic RSI SignalADXR with DI+/DI-
16 21 May B DEMA 2DEMA 3KAMA 1KAMA 2KAMA 3KAMA 4MIDPOINT Slope 2MIDPOINT Slope 3MIDPOINT Slope 4T3 Slope 1T3 Slope 2TEMA Price 2TEMA Price 3TRIMA Slope 1TRIMA Slope 2SAR CrossoverPLUS_DI Threshold 1PLUS_DI Threshold 2ROCR Threshold 4WILLR Exit OverboughtBOP Smoothed ThresholdChaikin ADOSC Zero CrossADXR with DI+/DI-Daily Pivot Point 1CMO Divergence 1
17 20 May B KAMA 2KAMA 3KAMA 4MIDPOINT Slope 4T3 Slope 1T3 Slope 2TRIMA Slope 1TRIMA Slope 2AROONOSC 2CCI Crossover 1CCI Crossover 2CCI Crossover 3PLUS_DI Threshold 1PLUS_DI Threshold 2ROC Threshold 1ROCR Threshold 2ROCR Threshold 4ADXR with DI+/DI-Ichimoku 1
18 19 May B KAMA 1KAMA 2KAMA 3KAMA 4MIDPOINT Slope 1MIDPOINT Slope 4T3 Slope 1T3 Slope 2TEMA Price 2TEMA Price 3TRIMA Slope 1AROONOSC 1AROONOSC 3PLUS_DI Threshold 1PLUS_DI Threshold 2RSI Exit OversoldWILLR Exit OversoldBOP Smoothed ThresholdMACD Crossover 2ADXR with DI+/DI-
19 18 May B DEMA 1DEMA 2DEMA 3KAMA 1KAMA 2KAMA 3KAMA 4WMA Crossover 3MIDPOINT Slope 1MIDPOINT Slope 2MIDPOINT Slope 3T3 Slope 1TEMA Price 2TEMA Price 3TRIMA Slope 1PLUS_DI Threshold 1PLUS_DI Threshold 2BOP Smoothed ThresholdChaikin AD CrossoverADXR with DI+/DI-Daily Pivot Point 1CMO Divergence 1
20 15 May B DEMA 1KAMA 1KAMA 2KAMA 3KAMA 4EMA Crossover 1WMA Crossover 2MIDPOINT Slope 1MIDPOINT Slope 2TEMA Price 1TEMA Price 2TRIMA Slope 1MOM Crossover 1MOM Crossover 2PLUS_DI Threshold 1PLUS_DI Threshold 2ROC Threshold 1ROC Threshold 2ROCR Threshold 1ROCR Threshold 2ROCR Threshold 3BOP Smoothed ThresholdMACD Crossover 1BBANDS Breakout 1ADXR with DI+/DI-Ichimoku 2Ichimoku 3Daily Pivot Point 1Rolling VWAPCMO Divergence 1
21 13 May B MIDPOINT Slope 4TEMA Price 3TRIMA Slope 2MOM Crossover 1PLUS_DI Threshold 1PLUS_DI Threshold 2ROC Threshold 1ROCR Threshold 2BBANDS Breakout 1Stochastic RSI SignalADXR with DI+/DI-
22 12 May S EMA Price Cross 1EMA Price Cross 2EMA Price Cross 4EMA Crossover 2WMA Crossover 1MIDPOINT Slope 1MIDPOINT Slope 4TEMA Price 1TEMA Price 2TEMA Price 3AROONOSC 3PLUS_DI Threshold 1PLUS_DI Threshold 2BOP Smoothed ThresholdSTOCH Normal Zone CrossADXR with DI+/DI-Daily Pivot Point 1CMO Divergence 1
23 11 May B DEMA 3EMA Price Cross 2EMA Crossover 2WMA Crossover 3MIDPOINT Slope 2T3 Slope 1TEMA Price 3TRIMA Slope 1MOM Crossover 1MOM Crossover 2PLUS_DI Threshold 1PLUS_DI Threshold 2ROC Threshold 1ROC Threshold 2ROCR Threshold 2ROCR Threshold 3WILLR Exit OverboughtBOP Smoothed ThresholdStochastic RSI SignalHammer / Hanging ManADXR with DI+/DI-Ichimoku 3
24 08 May N DEMA 3EMA Price Cross 2MIDPOINT Slope 4T3 Slope 1TEMA Price 1TEMA Price 3TRIMA Slope 1AROONOSC 1PLUS_DI Threshold 1PLUS_DI Threshold 2BOP Smoothed ThresholdBBANDS Breakout 1ADXR with DI+/DI-
25 07 May B DEMA 1DEMA 2DEMA 3KAMA 1KAMA 2KAMA 3WMA Crossover 2MIDPOINT Slope 1MIDPOINT Slope 2T3 Slope 1TEMA Price 2TEMA Price 3TRIMA Slope 1PLUS_DI Threshold 1PLUS_DI Threshold 2TRIX Crossover 2WILLR Exit OversoldBOP Smoothed ThresholdMACD Crossover 2BBANDS Breakout 1Percentage Price OscillatorIchimoku 2Ichimoku 3CMO Divergence 1
26 06 May S DEMA 2DEMA 3EMA Price Cross 2KAMA 1EMA Crossover 1WMA Crossover 1TEMA Price 2TEMA Price 3PLUS_DI Threshold 1PLUS_DI Threshold 2ROCR Threshold 1BOP Smoothed ThresholdADXR with DI+/DI-CMO Divergence 1CMO Divergence 2
27 05 May S DEMA 3KAMA 2KAMA 3KAMA 4MIDPOINT Slope 2T3 Slope 1T3 Slope 2TEMA Price 3TRIMA Slope 1TRIMA Slope 2PLUS_DI Threshold 1PLUS_DI Threshold 2BOP Smoothed ThresholdDonchian ChannelDaily Pivot Point 1CMO Divergence 1
28 26 Feb S DEMA 2DEMA 3KAMA 1KAMA 2KAMA 3KAMA 4MIDPOINT Slope 1T3 Slope 1T3 Slope 2TEMA Price 3TRIMA Slope 1TRIMA Slope 2PLUS_DI Threshold 1PLUS_DI Threshold 2BOP Smoothed ThresholdDEMA with ATR 2DEMA with ATR 3CMO Divergence 1
29 25 Feb S DEMA 1DEMA 2DEMA 3KAMA 1KAMA 2KAMA 3KAMA 4MIDPOINT Slope 1MIDPOINT Slope 4T3 Slope 1T3 Slope 2TEMA Price 2TEMA Price 3TRIMA Slope 1TRIMA Slope 2CMO Crossover 2PLUS_DI Threshold 1PLUS_DI Threshold 2BOP Smoothed ThresholdDEMA with ATR 2DEMA with ATR 3Volume SpikeDonchian ChannelCMO Divergence 1
30 24 Feb S DEMA 1DEMA 2DEMA 3KAMA 1KAMA 2KAMA 3KAMA 4MIDPOINT Slope 1MIDPOINT Slope 2MIDPOINT Slope 3MIDPOINT Slope 4T3 Slope 1T3 Slope 2TEMA Price 1TEMA Price 2TEMA Price 3TRIMA Slope 1CMO Crossover 1PLUS_DI Threshold 1PLUS_DI Threshold 2BOP Smoothed ThresholdDEMA with ATR 1DEMA with ATR 2DEMA with ATR 3Volume SpikeDonchian ChannelDaily Pivot Point 1CMO Divergence 1

Users forecasts for Xbrane Biopharma AB (XBRANE)

What is your prediction?

In this section, you can easily predict without user registration. See also other users predictions.

What is your prediction?

Xbrane Biopharma AB (XBRANE) predictions by visitors

Please fill in your email
Please fill in your Text
CAPTCHA Image
Please fill in your Captcha

Comments